Abstract:Nucleotide excision repair (NER) is a versatile pathway that removes helix-distorting DNA lesions from the genomes of organisms across the evolutionary scale, from bacteria to humans. The serial steps in NER involve recognition of lesions, adducts or structures that disrupt the DNA double helix, removal of a short oligonucleotide containing the offending lesion, synthesis of a repair patch copying the opposite undamaged strand, and ligation, to restore the DNA to its original form. Transcription-coupled repair… Show more
“…2). Backtracking of the EC exposes the lesion to UvrABC, thereby promoting repair [32][56][10]. This action of UvrD may be succeeded by its function in dissociating the oligonucleotide resulting from the double incision of the DNA.…”
Section: Tcr In E Colimentioning
confidence: 99%
“…In addition to marking DNA damage, RNAP provides another advantage to TCR by transiently opening the nucleosome structure during transcription [10]. Although the sequence of events in human TCR is similar to that in bacteria, the process is more complicated with respect to the number of proteins involved and their interplay [12][82].…”
Section: Tcr In Human Cellsmentioning
confidence: 99%
“…The lesion-bearing oligonucleotide is then expelled and new DNA is synthesized using the undamaged strand as a template. Finally, the new DNA is ligated to the adjacent strand [10][11][12]. Blockage of the RNAP at the damaged site is the general trigger for TCR [13][14][15].…”
Section: Introductionmentioning
confidence: 99%
“…Several of these mutations have also been linked to cancer and aging [20][21][22]. The severe developmental problems that characterize Cockayne syndrome do not occur in UV-sensitive syndrome even though the causal mutations can be in either CSA or CSB [10]. However, non-productive engagement of TCR at or near naturally occurring non-canonical DNA structures can be mutagenic [12][23].…”
Transcription-coupled DNA repair (TCR) acts on lesions in the transcribed strand of active genes. Helix distorting adducts and other forms of DNA damage often interfere with the progression of the transcription apparatus. Prolonged stalling of RNA polymerase can promote genome instability and also induce cell cycle arrest and apoptosis. These generally unfavorable events are counteracted by RNA polymerase-mediated recruitment of specific proteins to the sites of DNA damage to perform TCR and eventually restore transcription. In this perspective we discuss the decision-making process to employ TCR and we elucidate the intricate biochemical pathways leading to TCR in E. coli and human cells.
“…2). Backtracking of the EC exposes the lesion to UvrABC, thereby promoting repair [32][56][10]. This action of UvrD may be succeeded by its function in dissociating the oligonucleotide resulting from the double incision of the DNA.…”
Section: Tcr In E Colimentioning
confidence: 99%
“…In addition to marking DNA damage, RNAP provides another advantage to TCR by transiently opening the nucleosome structure during transcription [10]. Although the sequence of events in human TCR is similar to that in bacteria, the process is more complicated with respect to the number of proteins involved and their interplay [12][82].…”
Section: Tcr In Human Cellsmentioning
confidence: 99%
“…The lesion-bearing oligonucleotide is then expelled and new DNA is synthesized using the undamaged strand as a template. Finally, the new DNA is ligated to the adjacent strand [10][11][12]. Blockage of the RNAP at the damaged site is the general trigger for TCR [13][14][15].…”
Section: Introductionmentioning
confidence: 99%
“…Several of these mutations have also been linked to cancer and aging [20][21][22]. The severe developmental problems that characterize Cockayne syndrome do not occur in UV-sensitive syndrome even though the causal mutations can be in either CSA or CSB [10]. However, non-productive engagement of TCR at or near naturally occurring non-canonical DNA structures can be mutagenic [12][23].…”
Transcription-coupled DNA repair (TCR) acts on lesions in the transcribed strand of active genes. Helix distorting adducts and other forms of DNA damage often interfere with the progression of the transcription apparatus. Prolonged stalling of RNA polymerase can promote genome instability and also induce cell cycle arrest and apoptosis. These generally unfavorable events are counteracted by RNA polymerase-mediated recruitment of specific proteins to the sites of DNA damage to perform TCR and eventually restore transcription. In this perspective we discuss the decision-making process to employ TCR and we elucidate the intricate biochemical pathways leading to TCR in E. coli and human cells.
“…2 The two subpathways of NER,
global genomic NER (GG-NER) and transcription-coupled NER (TC-NER),
employ a common set of proteins including TFIIH, XPG, XPA, RPA, and
ERCC1-XPF, and are essentially the same except for differences in
their lesion-recognition mechanisms. 2,12−15 In TC-NER, the RNA polymerase acts as the lesion sensor; in our
current focus of GG-NER, the XPC-RAD23B complex detects lesion-containing
DNA, aided in cells by centrin 2 and UV-DDB1/2 for cyclobutane pyrimidine
dimers (CPDs). 16−20 UV-DDB1/2 is believed to hand off CPD lesions to XPC, 2,21 and studies with CPD lesions in cells suggest that UV-DDB1/2 facilitates
NER in chromatin.…”
The xeroderma pigmentosum C protein
complex (XPC) recognizes a
variety of environmentally induced DNA lesions and is the key in initiating
their repair by the nucleotide excision repair (NER) pathway. When
bound to a lesion, XPC flips two nucleotide pairs that include the
lesion out of the DNA duplex, yielding a productively bound complex
that can lead to successful lesion excision. Interestingly, the efficiencies
of NER vary greatly among different lesions, influencing their toxicity
and mutagenicity in cells. Though differences in XPC binding may influence
NER efficiency, it is not understood whether XPC utilizes different
mechanisms to achieve productive binding with different lesions. Here,
we investigated the well-repaired 10R-(+)-cis-anti-benzo[a]pyrene-N2-dG (cis-B[a]P-dG)
DNA adduct in a duplex containing normal partner C opposite the lesion.
This adduct is derived from the environmental pro-carcinogen benzo[a]pyrene and is likely to be encountered by NER in the cell.
We have extensively investigated its binding to the yeast XPC orthologue,
Rad4, using umbrella sampling with restrained molecular dynamics simulations
and free energy calculations. The NMR solution structure of this lesion
in duplex DNA has shown that the dC complementary to the adducted
dG is flipped out of the DNA duplex in the absence of XPC. However,
it is not known whether the “pre-flipped” base would
play a role in its recognition by XPC. Our results show that Rad4
first captures the displaced dC, which is followed by a tightly coupled
lesion-extruding pathway for productive binding. This binding path
differs significantly from the one deduced for the small cis-syn cyclobutane pyrimidine dimer lesion opposite mismatched thymines
[MuH.MuH.26270861Biochemistry20155452637]. The possibility
of multiple paths that lead to productive binding to XPC is consistent
with the versatile lesion recognition by XPC that is required for
successful NER.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.